PMID- 34025357 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210526 IS - 1662-5102 (Print) IS - 1662-5102 (Electronic) IS - 1662-5102 (Linking) VI - 15 DP - 2021 TI - Beta-Secretase 1 Underlies Reactive Astrocytes and Endothelial Disruption in Neurodegeneration. PG - 656832 LID - 10.3389/fncel.2021.656832 [doi] LID - 656832 AB - Dysfunction in the neurovascular unit (NVU) is a key component in the progressive deterioration of Alzheimer's disease (AD) and is critical in vascular dementia. Recent studies have shown that inflammation plays early and perhaps causal roles in the pathogenesis of AD related to NVU damage, possibly in part by overactivating the aspartic acid protease activity of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1), which until now has almost solely been studied in the context of the beta-amyloid cascade. In this study, we analyzed the relationship of BACE1 with astrocytes and blood vessels in human brains with sporadic and familial dementia [Autosomal dominant cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), sporadic Alzheimer's disease (SAD), and familial Alzheimer's disease (FAD)] and how BACE1 inhibition affects astrocytes and endothelial cells under conditions of glutamate toxicity. Our results show increased BACE1, PHF (Paired helical filaments)-tau and GFAP (Glial Fibrillary Acid Protein) immunoreactivity (IR) in the CA1 hippocampal regions of FAD and SAD brains. Furthermore, BACE1 immunoprecipitated with GFAP in tissue samples from all study cases, but their immunofluorescence close to (10 mum(3)) or overlapping blood vessels was only increased in FAD and SAD brains, and PHF-tau was present around the vessels mainly in FAD brains. Interestingly, the increased BACE1 levels were associated with reactive astrocytes, characterized by morphological changes and upregulation of GFAP under pathological and stressful conditions, and endothelial disruption by glutamate excitotoxicity, and these effects were reversed by BACE1 inhibition; further, BACE1-inhibited astrocytes protected endothelial cell integrity by preserving zonula occludens-1 (ZO-1) distribution and decreasing the expression of inflammatory markers. Taken together, these findings suggest that BACE1 dysregulation in astrocytes may have a role in the alterations in NVU integrity implicated in neurodegeneration. CI - Copyright (c) 2021 Chacon-Quintero, Pineda-Lopez, Villegas-Lanau, Posada-Duque and Cardona-Gomez. FAU - Chacon-Quintero, Maria Victoria AU - Chacon-Quintero MV AD - Neuroscience Group of Antioquia, Faculty of Medicine, University of Antioquia, Cellular and Molecular Neurobiology Area, Medellin, Colombia. AD - Institute of Biology, Faculty of Exact and Natural Sciences, University of Antioquia, Medellin, Colombia. FAU - Pineda-Lopez, Lina Gisela AU - Pineda-Lopez LG AD - Neuroscience Group of Antioquia, Faculty of Medicine, University of Antioquia, Cellular and Molecular Neurobiology Area, Medellin, Colombia. AD - Institute of Biology, Faculty of Exact and Natural Sciences, University of Antioquia, Medellin, Colombia. FAU - Villegas-Lanau, Carlos Andres AU - Villegas-Lanau CA AD - Neurobank, Faculty of Medicine, SIU, University of Antioquia, Medellin, Colombia. FAU - Posada-Duque, Rafael AU - Posada-Duque R AD - Neuroscience Group of Antioquia, Faculty of Medicine, University of Antioquia, Cellular and Molecular Neurobiology Area, Medellin, Colombia. AD - Institute of Biology, Faculty of Exact and Natural Sciences, University of Antioquia, Medellin, Colombia. FAU - Cardona-Gomez, Gloria Patricia AU - Cardona-Gomez GP AD - Neuroscience Group of Antioquia, Faculty of Medicine, University of Antioquia, Cellular and Molecular Neurobiology Area, Medellin, Colombia. LA - eng PT - Journal Article DEP - 20210506 PL - Switzerland TA - Front Cell Neurosci JT - Frontiers in cellular neuroscience JID - 101477935 PMC - PMC8136516 OTO - NOTNLM OT - BACE1 OT - endothelial disruption OT - neurodegeneration OT - neurovascular unit OT - reactive astrocytes COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/05/25 06:00 MHDA- 2021/05/25 06:01 PMCR- 2021/01/01 CRDT- 2021/05/24 08:03 PHST- 2021/01/21 00:00 [received] PHST- 2021/04/12 00:00 [accepted] PHST- 2021/05/24 08:03 [entrez] PHST- 2021/05/25 06:00 [pubmed] PHST- 2021/05/25 06:01 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fncel.2021.656832 [doi] PST - epublish SO - Front Cell Neurosci. 2021 May 6;15:656832. doi: 10.3389/fncel.2021.656832. eCollection 2021.